IL189541A0 - Stable solid formulation of sertindole - Google Patents
Stable solid formulation of sertindoleInfo
- Publication number
- IL189541A0 IL189541A0 IL189541A IL18954108A IL189541A0 IL 189541 A0 IL189541 A0 IL 189541A0 IL 189541 A IL189541 A IL 189541A IL 18954108 A IL18954108 A IL 18954108A IL 189541 A0 IL189541 A0 IL 189541A0
- Authority
- IL
- Israel
- Prior art keywords
- sertindole
- solid formulation
- stable solid
- stable
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200501255 | 2005-09-08 | ||
| PCT/DK2006/050038 WO2007065448A1 (en) | 2005-09-08 | 2006-09-06 | Stable solid formulation of sertindole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL189541A0 true IL189541A0 (en) | 2008-08-07 |
Family
ID=37697999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL189541A IL189541A0 (en) | 2005-09-08 | 2008-02-14 | Stable solid formulation of sertindole |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1924261A1 (en) |
| JP (1) | JP2009507051A (en) |
| KR (1) | KR20080042102A (en) |
| CN (1) | CN101257906A (en) |
| AR (1) | AR056475A1 (en) |
| AU (1) | AU2006322460A1 (en) |
| BR (1) | BRPI0615630A2 (en) |
| CA (1) | CA2621866A1 (en) |
| EA (1) | EA013167B1 (en) |
| IL (1) | IL189541A0 (en) |
| MX (1) | MX2008002290A (en) |
| NO (1) | NO20081721L (en) |
| NZ (1) | NZ565330A (en) |
| TW (1) | TW200738239A (en) |
| UA (1) | UA97349C2 (en) |
| WO (1) | WO2007065448A1 (en) |
| ZA (1) | ZA200801169B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| KR20110117133A (en) * | 2009-01-29 | 2011-10-26 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | Orally disintegrating tablet having inner core |
| FR2943061B1 (en) * | 2009-03-13 | 2011-02-25 | Rhodia Operations | ORGANOPHOSPHORUS COMPOUNDS, CATALYTIC SYSTEMS COMPRISING THESE COMPOUNDS, AND HYDROCYANATION OR HYDROFORMYLATION PROCESS USING THESE CATALYTIC SYSTEMS |
| KR102318720B1 (en) | 2012-07-16 | 2021-10-28 | 피브로겐, 인크. | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid |
| US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
| PL3003284T3 (en) | 2013-06-06 | 2020-08-10 | Fibrogen, Inc. | Pharmaceutical formulations of a hif hydroxylase inhibitor |
| EP3043793B1 (en) | 2013-11-19 | 2021-01-06 | Siga Technologies Inc. | Rehydration of micronized tecovirimat monohydrate |
| JP2018172361A (en) * | 2016-10-14 | 2018-11-08 | 大原薬品工業株式会社 | Solid preparation containing duloxetine, having improved light stability |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04346929A (en) * | 1991-05-22 | 1992-12-02 | Takada Seiyaku Kk | Bromocriptine mesylate preparation having stability to light |
| AU2587297A (en) * | 1996-03-25 | 1997-10-17 | Eli Lilly And Company | Method for treating pain |
| ZA973433B (en) * | 1996-04-24 | 1997-12-10 | Shionogi & Co | A sertindole-containing preparation and a method for producing the same. |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
-
2006
- 2006-06-09 UA UAA200803569A patent/UA97349C2/en unknown
- 2006-08-17 TW TW095130202A patent/TW200738239A/en unknown
- 2006-08-29 AR ARP060103764A patent/AR056475A1/en not_active Application Discontinuation
- 2006-09-06 MX MX2008002290A patent/MX2008002290A/en not_active Application Discontinuation
- 2006-09-06 KR KR1020087004910A patent/KR20080042102A/en not_active Application Discontinuation
- 2006-09-06 CN CNA2006800323410A patent/CN101257906A/en active Pending
- 2006-09-06 JP JP2008529472A patent/JP2009507051A/en not_active Withdrawn
- 2006-09-06 EP EP06846966A patent/EP1924261A1/en not_active Withdrawn
- 2006-09-06 NZ NZ565330A patent/NZ565330A/en not_active IP Right Cessation
- 2006-09-06 AU AU2006322460A patent/AU2006322460A1/en not_active Abandoned
- 2006-09-06 CA CA002621866A patent/CA2621866A1/en not_active Abandoned
- 2006-09-06 WO PCT/DK2006/050038 patent/WO2007065448A1/en active Application Filing
- 2006-09-06 BR BRPI0615630A patent/BRPI0615630A2/en not_active IP Right Cessation
- 2006-09-06 EA EA200800774A patent/EA013167B1/en not_active IP Right Cessation
- 2006-09-06 ZA ZA200801169A patent/ZA200801169B/en unknown
-
2008
- 2008-02-14 IL IL189541A patent/IL189541A0/en unknown
- 2008-04-08 NO NO20081721A patent/NO20081721L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR056475A1 (en) | 2007-10-10 |
| UA97349C2 (en) | 2012-02-10 |
| JP2009507051A (en) | 2009-02-19 |
| NO20081721L (en) | 2008-04-08 |
| EA013167B1 (en) | 2010-02-26 |
| CN101257906A (en) | 2008-09-03 |
| WO2007065448A1 (en) | 2007-06-14 |
| EP1924261A1 (en) | 2008-05-28 |
| MX2008002290A (en) | 2008-03-14 |
| NZ565330A (en) | 2011-06-30 |
| CA2621866A1 (en) | 2007-06-14 |
| ZA200801169B (en) | 2010-07-28 |
| TW200738239A (en) | 2007-10-16 |
| BRPI0615630A2 (en) | 2016-11-16 |
| EA200800774A1 (en) | 2008-06-30 |
| AU2006322460A1 (en) | 2007-06-14 |
| KR20080042102A (en) | 2008-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2424581B (en) | Formulations | |
| PL2335782T3 (en) | Use of compositions comprising HFCO-1233zd | |
| ZA200808773B (en) | Stable emulsion formulations | |
| IL188915A0 (en) | Liquid formulations | |
| ZA200801773B (en) | New formulation | |
| EP1909584A4 (en) | Prenylflavonoid formulations | |
| HK1198914A1 (en) | Novel dosage formulation | |
| TWI370115B (en) | New formulation | |
| IL189935A0 (en) | Solid formulation of fungicidal mixtures | |
| GB0507208D0 (en) | Anti-inflammatory formulation | |
| GB0526419D0 (en) | Formulation | |
| GB0505569D0 (en) | Formulations | |
| EP1951693A4 (en) | Solid formulations | |
| GB0517673D0 (en) | Formulation | |
| IL189541A0 (en) | Stable solid formulation of sertindole | |
| EP1894565A4 (en) | Stabilized milnacipran formulation | |
| ZA200802953B (en) | Solid vaccine formulation | |
| GB0501030D0 (en) | Formulation | |
| HK1120414A1 (en) | Pharmaceutical formulation of nitrooxyderivatives of nsaids | |
| LT1928232T (en) | Solid formulation | |
| EP1951258A4 (en) | Liquid formulations | |
| GB0500807D0 (en) | Formulation | |
| GB0507811D0 (en) | Formulation | |
| GB0510788D0 (en) | Formulation | |
| GB0518878D0 (en) | Formulations |